Trial Profile
A phase II trial of vesanoid (tretinoin, all-trans-retinoic acid) and taxol (paclitaxel) in patients with stage IV breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jan 2006
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Tretinoin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 Jan 2006 New trial record.